Analystreport

Rubius Therapeutics, Inc. (NASDAQ: RUBY) had its price target lowered by analysts at HC Wainwright from $40.00 to $15.00.

Rubius Therapeutics, Inc.  (RUBY) 
Last rubius therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report